Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Pienta

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Advances in Radiation Oncology|August 12, 2017
A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomyWilliam C Jackson, Felix Y Feng, Stephanie Daignault, et al.
European Urology Oncology|August 9, 2023
Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate CancerPhilip Sutera, Amol C Shetty, Yang Song, et al.
The Journal of Urology|January 9, 2023
Reply by AuthorsMichael T Schweizer, Lawrence True, Roman Gulati, et al.
The Journal of Urology|January 9, 2023
Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical TrialMichael T Schweizer, Lawrence True, Roman Gulati, et al.
European Urology Oncology|June 16, 2020
Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate CancerMatthew P Deek, Kekoa Taparra, Ryan Phillips, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2020
Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate CancerMatthew P Deek, Kekoa Taparra, Dyda Dao, et al.
Advances in Radiation Oncology|May 27, 2024
Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate CancerPhilip Sutera, Matthew P Deek, Rebecca A Deek, et al.
European Urology|May 12, 2023
Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate CancerPhilip Sutera, Yang Song, Kim Van der Eecken, et al.
Cancer Cell|October 11, 2017
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF SignalingEric G Bluemn, Ilsa M Coleman, Jared M Lucas, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Advances in Radiation Oncology|August 12, 2017
A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomyWilliam C Jackson, Felix Y Feng, Stephanie Daignault, et al.
European Urology Oncology|August 9, 2023
Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate CancerPhilip Sutera, Amol C Shetty, Yang Song, et al.
The Journal of Urology|January 9, 2023
Reply by AuthorsMichael T Schweizer, Lawrence True, Roman Gulati, et al.
The Journal of Urology|January 9, 2023
Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical TrialMichael T Schweizer, Lawrence True, Roman Gulati, et al.
European Urology Oncology|June 16, 2020
Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate CancerMatthew P Deek, Kekoa Taparra, Ryan Phillips, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2020
Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate CancerMatthew P Deek, Kekoa Taparra, Dyda Dao, et al.
Advances in Radiation Oncology|May 27, 2024
Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate CancerPhilip Sutera, Matthew P Deek, Rebecca A Deek, et al.
European Urology|May 12, 2023
Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate CancerPhilip Sutera, Yang Song, Kim Van der Eecken, et al.
Cancer Cell|October 11, 2017
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF SignalingEric G Bluemn, Ilsa M Coleman, Jared M Lucas, et al.
Pageof 3